DERIVADOS DE BENZOCICLOHEXILIMIDAZOLETIONA

The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PHILIP J. TEITELBAUM, OWEN W. GOODING, COUNDE O'YANG, KEITH A. M. WALKER, DAVID B. REPKE, ALEXANDER V. MUEHLDORF, REKHA P. BANSAL, GREGORY R. MARTINEZ, ROGER L. WHITING
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PHILIP J. TEITELBAUM
OWEN W. GOODING
COUNDE O'YANG
KEITH A. M. WALKER
DAVID B. REPKE
ALEXANDER V. MUEHLDORF
REKHA P. BANSAL
GREGORY R. MARTINEZ
ROGER L. WHITING
description The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT757677EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT757677EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT757677EE3</originalsourceid><addsrcrecordid>eNrjZNBycQ3yDHN08Q9WcHFVcHL1i_J39nT28fdwjfD08fT1dHGM8vdxDfH093PkYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxASHmpuZm5uaursaEVQAA7bIkmA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVADOS DE BENZOCICLOHEXILIMIDAZOLETIONA</title><source>esp@cenet</source><creator>PHILIP J. TEITELBAUM ; OWEN W. GOODING ; COUNDE O'YANG ; KEITH A. M. WALKER ; DAVID B. REPKE ; ALEXANDER V. MUEHLDORF ; REKHA P. BANSAL ; GREGORY R. MARTINEZ ; ROGER L. WHITING</creator><creatorcontrib>PHILIP J. TEITELBAUM ; OWEN W. GOODING ; COUNDE O'YANG ; KEITH A. M. WALKER ; DAVID B. REPKE ; ALEXANDER V. MUEHLDORF ; REKHA P. BANSAL ; GREGORY R. MARTINEZ ; ROGER L. WHITING</creatorcontrib><description>The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.</description><edition>7</edition><language>por</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; APPARATUS THEREFOR ; CHEMISTRY ; GENERAL METHODS OF ORGANIC CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031128&amp;DB=EPODOC&amp;CC=PT&amp;NR=757677E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031128&amp;DB=EPODOC&amp;CC=PT&amp;NR=757677E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PHILIP J. TEITELBAUM</creatorcontrib><creatorcontrib>OWEN W. GOODING</creatorcontrib><creatorcontrib>COUNDE O'YANG</creatorcontrib><creatorcontrib>KEITH A. M. WALKER</creatorcontrib><creatorcontrib>DAVID B. REPKE</creatorcontrib><creatorcontrib>ALEXANDER V. MUEHLDORF</creatorcontrib><creatorcontrib>REKHA P. BANSAL</creatorcontrib><creatorcontrib>GREGORY R. MARTINEZ</creatorcontrib><creatorcontrib>ROGER L. WHITING</creatorcontrib><title>DERIVADOS DE BENZOCICLOHEXILIMIDAZOLETIONA</title><description>The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>APPARATUS THEREFOR</subject><subject>CHEMISTRY</subject><subject>GENERAL METHODS OF ORGANIC CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBycQ3yDHN08Q9WcHFVcHL1i_J39nT28fdwjfD08fT1dHGM8vdxDfH093PkYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxASHmpuZm5uaursaEVQAA7bIkmA</recordid><startdate>20031128</startdate><enddate>20031128</enddate><creator>PHILIP J. TEITELBAUM</creator><creator>OWEN W. GOODING</creator><creator>COUNDE O'YANG</creator><creator>KEITH A. M. WALKER</creator><creator>DAVID B. REPKE</creator><creator>ALEXANDER V. MUEHLDORF</creator><creator>REKHA P. BANSAL</creator><creator>GREGORY R. MARTINEZ</creator><creator>ROGER L. WHITING</creator><scope>EVB</scope></search><sort><creationdate>20031128</creationdate><title>DERIVADOS DE BENZOCICLOHEXILIMIDAZOLETIONA</title><author>PHILIP J. TEITELBAUM ; OWEN W. GOODING ; COUNDE O'YANG ; KEITH A. M. WALKER ; DAVID B. REPKE ; ALEXANDER V. MUEHLDORF ; REKHA P. BANSAL ; GREGORY R. MARTINEZ ; ROGER L. WHITING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT757677EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2003</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>APPARATUS THEREFOR</topic><topic>CHEMISTRY</topic><topic>GENERAL METHODS OF ORGANIC CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PHILIP J. TEITELBAUM</creatorcontrib><creatorcontrib>OWEN W. GOODING</creatorcontrib><creatorcontrib>COUNDE O'YANG</creatorcontrib><creatorcontrib>KEITH A. M. WALKER</creatorcontrib><creatorcontrib>DAVID B. REPKE</creatorcontrib><creatorcontrib>ALEXANDER V. MUEHLDORF</creatorcontrib><creatorcontrib>REKHA P. BANSAL</creatorcontrib><creatorcontrib>GREGORY R. MARTINEZ</creatorcontrib><creatorcontrib>ROGER L. WHITING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PHILIP J. TEITELBAUM</au><au>OWEN W. GOODING</au><au>COUNDE O'YANG</au><au>KEITH A. M. WALKER</au><au>DAVID B. REPKE</au><au>ALEXANDER V. MUEHLDORF</au><au>REKHA P. BANSAL</au><au>GREGORY R. MARTINEZ</au><au>ROGER L. WHITING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVADOS DE BENZOCICLOHEXILIMIDAZOLETIONA</title><date>2003-11-28</date><risdate>2003</risdate><abstract>The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_PT757677EE
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title DERIVADOS DE BENZOCICLOHEXILIMIDAZOLETIONA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T01%3A59%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PHILIP%20J.%20TEITELBAUM&rft.date=2003-11-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT757677EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true